The technology, developed and patented jointly by investigators from Brigham and Women’s Hospital and Massachusetts General Hospital, both based in Boston, uses AI for image-based evaluation of human embryos in order to improve in-vitro fertilization success rates, according to a June 22 press release.
Fujifilm Irvine Scientific plans to bring the technology to other U.S. fertility clinics.
“With assistance from our AI system, embryologists will have a valuable tool to use in their effort to identify and select embryos with the highest chance of resulting in pregnancy,” said Charles Bormann, PhD, IVF laboratory director of Massachusetts General Hospital.
The terms of the acquisition were not disclosed.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
